Diabetes Care Devices | Market Insights | US | 2024
The US diabetes care device market has shown strong recovery from the short-term negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the coming years. Market growth will be driven by the introduction of new technologies and innovative products, such as hybrid closed-loop insulin pumps and patch pumps. These advanced products are anticipated to command higher prices and contribute to strong market growth over the forecast period. In particular, the CGM device segment will see rapid growth over the forecast period, supported by recent CMS updates to Medicare coverage that have relaxed the criteria for beneficiaries to qualify for CGM reimbursement, improving patient access to these devices.
This Medtech 360 Report provides comprehensive data and analysis on the state of the diabetes care device market in the US from 2019 through 2032.
